Procept BioRobotics Corp’s recently made public that its President, CEO Zadno Reza unloaded Company’s shares for reported $2.57 million on Dec 04 ’24. In the deal valued at $97.22 per share,26,423 shares were sold. As a result of this transaction, Zadno Reza now holds 152,762 shares worth roughly $10.66 million.
Then, Nouri Alaleh sold 28,092 shares, generating $2,728,574 in total proceeds. Upon selling the shares at $97.13, the EVP, CLO, CORP. SEC. now owns 52,472 shares.
Before that, REZA ZADNO bought 26,423 shares. Procept BioRobotics Corp shares valued at $2,549,291 were divested by the Director at a price of $96.48 per share.
Morgan Stanley initiated its Procept BioRobotics Corp [PRCT] rating to an Overweight in a research note published on December 02, 2024; the price target was $105. A number of analysts have revised their coverage, including Jefferies’s analysts, who began to cover the stock in mid November with a ‘”a Hold”‘ rating. Piper Sandler began covering PRCT with “an Overweight” recommendation on August 11, 2023. William Blair started covering the stock on May 31, 2023. It rated PRCT as “an Outperform”.
Price Performance Review of PRCT
On Tuesday, Procept BioRobotics Corp [NASDAQ:PRCT] saw its stock fall -8.25% to $69.75. Over the last five days, the stock has lost -15.87%. Procept BioRobotics Corp shares have fallen nearly -13.38% since the year began. Nevertheless, the stocks have risen 54.62% over the past one year. While a 52-week high of $103.81 was reached on 01/06/25, a 52-week low of $44.02 was recorded on 01/21/25. SMA at 50 days reached $88.83, while 200 days put it at $73.03.
Levels Of Support And Resistance For PRCT Stock
The 24-hour chart illustrates a support level at 66.50, which if violated will result in even more drops to 63.24. On the upside, there is a resistance level at 74.98. A further resistance level may holdings at 80.20. The Relative Strength Index (RSI) on the 14-day chart is 25.90, which indicates oversold technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -7.00, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 93.91%. Stochastics %K at 3.34% indicates the stock is a buying.
How much short interest is there in Procept BioRobotics Corp?
A steep rise in short interest was recorded in Procept BioRobotics Corp stocks on 2024-12-31, growing by 0.79 million shares to a total of 6.89 million shares. Yahoo Finance data shows the prior-month short interest on 2024-11-29 was 6.09 million shares. There was a rise of 11.55%, which implies that there is a positive sentiment for the stock.
The most recent change occurred on October 31, 2022 when BTIG Research began covering the stock and recommended ‘”a Neutral”‘ rating .
